Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

New modulators of immunotherapeutic agents described by Altachem and U. of Alberta

Oct. 7, 2002

Igeneon licenses IGN-301 from Novartis

Oct. 4, 2002

Avax signs distribution agreement with Ferrer for AC Vaccine technology

Oct. 4, 2002

Potential use of the HSPPC-96 vaccine in patients with metastatic renal cell carcinoma

Oct. 4, 2002

Allovectin-7 update

Oct. 1, 2002

Monoclonal antibodies targeting human BST2

Oct. 1, 2002

G17DT granted fast track status for pancreatic cancer

Sep. 27, 2002

Update on phase II and III clinical studies of Theratope in breast cancer

Sep. 27, 2002

Nycomed licenses TransMID from KS Biomedix in Europe

Sep. 20, 2002

Edrecolomab effective against bone marrow metastases of breast cancer

Sep. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...